Overview Financials News + Filings Key Docs Ownership
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Brainsway Ltd. (BWAY)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/09/2023 |
6-K
| Quarterly results |
| 05/17/2023 |
6-K
| Quarterly results |
| 11/16/2022 |
6-K
| Quarterly results |
| 08/10/2022 |
6-K
| Quarterly results |
| 05/11/2022 |
6-K
| Quarterly results |
| 11/17/2021 |
6-K
| Quarterly results |
| 08/11/2021 |
6-K
| Quarterly results |
| 05/20/2021 |
6-K
| Quarterly results |
| 11/18/2020 |
6-K
| Quarterly results |
| 08/12/2020 |
6-K
| Quarterly results |
| 06/24/2020 |
6-K
| Quarterly results |
| 11/25/2019 |
6-K
| Quarterly results|
Docs:
|
"FORM 6-K",
"BrainsWay Reports Third Quarter 2019 Financial Results and Operational Highlights Third quarter revenues were $5.9 million, up 38% over the same quarter in the prior year JERUSALEM, Israel and HACKENSACK, N.J., Nov. 25, 2019 -- BrainsWay Ltd. , a global leader in the advanced non-invasive treatment of brain disorders, today reported financial results for the quarter ended September 30, 2019, and provided an operational update. “We are pleased with our solid performance in the third quarter of this year,” said Dr. David Zacut, Chairman, Interim CEO and a founder of BrainsWay. “These positive results reflect the continued increase in demand for our Deep Transcranial Magnetic Stimulation system and the sustained momentum of our business during the Company’s strategic transition to U.S.-based ..." |
|
| 08/26/2019 |
6-K
| Quarterly results |
| 05/29/2019 |
6-K
| Quarterly results |
|
|